Immunogenicity in CAR T cell immunotherapy
<p>Currently, the most accessible forms of cancer treatment include surgery, chemotherapy, and radiation. However, these forms of treatment may damage or destroy healthy tissue as well as cancerous cells, resulting in side effects such as fatigue, hair loss, diarrhea, etc. Immunotherapy, an al...
Saved in:
Main Author: | Emily Yu (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2023-10-04.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New cell sources for CAR-based immunotherapy
by: Marzieh Mazinani, et al.
Published: (2023) -
Nanobody-based CAR-T cells for cancer immunotherapy
by: Pouya Safarzadeh Kozani, et al.
Published: (2022) -
Immunotherapy with CAR-T cells in paediatric haematology-oncology
by: Isabel Mirones, et al.
Published: (2020) -
CAR T-cell immunotherapy of B-cell malignancy: the story so far
by: Leena Halim, et al.
Published: (2020) -
CAR-NK cells for cancer immunotherapy: from bench to bedside
by: Leisheng Zhang, et al.
Published: (2022)